Rare Diseases
Rare Diseases is a key segment within the Healthcare sector, comprising 949+ companies actively operating in this space.
This segment represents businesses focused on specific activities and services within Healthcare. Companies in this segment share common characteristics, market positioning, and often face similar challenges and opportunities.
Browse the comprehensive directory of Rare Diseases companies to access detailed profiles, financial information, funding rounds, investor details, and other critical business intelligence for research, due diligence, and market analysis.
Discover leading companies in this segment, ranked by company performance and market presence.
mRNA-based therapeutics for diseases including cancer and infections are developed.
Gene therapies for rare diseases including retinal dystrophies are developed.
Therapeutics for genetic diseases are developed through targeted interventions.
Solutions for genetic diseases are developed using CRISPR-Cas9 genome editing.
Gene therapies for rare diseases are developed to treat patients.
Developing small molecules for control mechanisms and genes regulation for the treatment of rare diseases
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
RNA interference-based therapeutics are developed for multiple disorders.
Biologics platform developed for intracellular delivery in rare diseases.
Therapies for gastrointestinal diseases are developed by Phathom Pharmaceuticals.
Gene therapies for rare liver and eye diseases are developed.
Small molecule drugs for rare diseases are developed.
Genetic medicines are developed to address rare diseases.
Developer of antibodies to treat complement-mediated neurodegenerative diseases
Gene-based therapies are developed for genetic and acquired diseases.
Developer of drugs for treating rare and autoimmune diseases
Therapeutics for cancer and rare diseases are developed.
Developer of therapeutics for rare neurological diseases
Disease-modifying therapies for degenerative disorders are developed.
Developer of small molecule drugs for orphan & autoimmune diseases and antivirals
Explore Companies in Rare Diseases
Access detailed company profiles, financial data, funding information, and more for all companies in this segment.
View All Companies